On December 29, Alignment Healthcare’s Chief Information Officer Robert L. Scavo sold 69,541 shares of common stock in an open-market transaction valued at approximately $1.3 million, according to a Form 4 filing. The weighted average sale price was $18.74 per share. Post-transaction, Scavo retains 503,014 direct shares, with a remaining holding valued at roughly $9.53 million. This sale represented 12.2% of his direct holdings—well above his recent median sale size of 4.91% but smaller than a 100,863-share disposition executed in June 2025. No options, derivatives or indirect holdings were involved in this transaction.

Alignment Healthcare reported trailing-twelve-month revenue of $3.64 billion and a net loss of $20.81 million. Over the past year, the company’s share price rallied 78%. In its latest quarter, revenue climbed 43.5% year-over-year to $993.7 million, membership increased by nearly 26%, and adjusted EBITDA reached $32.4 million. Management raised full-year guidance across key metrics, reflecting robust Medicare Advantage plan enrollments in California, North Carolina and Nevada and continued margin improvement through its tech-enabled care coordination platform.

On January 6, 2026, Chief Medical Officer Kim Hyong sold 16,506 shares at an average price of $21.35 per share, following a December 29 sale of 12,694 shares at $18.74 each. After these transactions, Kim holds 333,133 shares, representing a 3.5% reduction from her prior position of 349,639 shares. Kim’s remaining stake underscores continued insider confidence despite realizing taxable events. Alignment Healthcare’s balance sheet shows a debt-to-equity ratio of 2.04 and a current ratio of 1.61, while its P/E stands at -203.72, reflecting ongoing investments in growth and member acquisition.